-
Company Insights
NewFIS – Competitor Profile
Fidelity National Information Services (FIS) is one of the leading payment and transactional service providers globally, offering end-to-end solutions that cover the entire payment value chain. It offers omni-channel solutions for merchants, banks, acquirers, payment services providers, businesses, and governments. It has made several acquisitions of complementary businesses, which has helped the company stay competitive in the market. In October 2014, FIS acquired Clear2Pay, a provider of banking and payments technology solutions, enabling FIS to expand its portfolio with new...
-
Analyst Opinions
Digital Challenger Banks – The Dawn of Profitability
Digital Challenger Banks Market Report Overview Digital-only banks have become commonplace across the world, offering a digital-first approach to banking that focuses on an improved customer experience. Historically, these banks have focused on customer acquisition at all costs, placing doubt on their ability to turn a profit in the long run. However, the tide seems to be changing, with a number of the neobanks examined in this report seeing their first glimpse of profitability. This review focuses on some of...
-
Product Insights
Secondary Progressive Multiple Sclerosis (SPMS) – Drugs In Development, 2023
Global Markets Direct’s, ‘Secondary Progressive Multiple Sclerosis (SPMS) - Drugs In Development, 2023’, provides an overview of the Secondary Progressive Multiple Sclerosis (SPMS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Secondary Progressive Multiple Sclerosis (SPMS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Relapsing Remitting Multiple Sclerosis (RRMS) – Drugs In Development, 2023
Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Drugs In Development, 2023’, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Relapsing Remitting Multiple Sclerosis (RRMS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Myocardial Infarction – Drugs In Development, 2023
Global Markets Direct’s, ‘Myocardial Infarction - Drugs In Development, 2023’, provides an overview of the Myocardial Infarction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myocardial Infarction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Plaque Psoriasis (Psoriasis Vulgaris) – Drugs In Development, 2023
Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Drugs In Development, 2023’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Plaque Psoriasis (Psoriasis Vulgaris), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Sector Analysis
NewCar Rental Market Size, Share, Trends and Analysis by Customer Type, Location, Rental Sales by Channel and Segment Forecast to 2027
Accessing the in-depth insights from the ‘Car Rental Market’ report can help you: Analyze the car rental industry with a brief overview. Enhance the target audience's comprehension of the total addressable market (TAM), offering valuable insights into market potential. Identify the key regions witnessing the highest number of market dynamic activities such as mergers & acquisitions and venture financing. Provide insights into car rentals as per geographic region. Identify key market trends driving the growth of the market Anticipate changes in...
-
Product Insights
NewHyaluronic Acid Fillers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hyaluronic Acid Fillers Pipeline Market Report Overview Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of the total HA is found in the skin. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation. The hyaluronic acid fillers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UMSC-01 in Relapsing Remitting Multiple Sclerosis (RRMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - UMSC-01 in Relapsing Remitting Multiple Sclerosis (RRMS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. UMSC-01 in Relapsing Remitting Multiple Sclerosis (RRMS) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UMSC-01 in Secondary Progressive Multiple Sclerosis (SPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - UMSC-01 in Secondary Progressive Multiple Sclerosis (SPMS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. UMSC-01 in Secondary Progressive Multiple Sclerosis (SPMS) Drug...